*October 2022*
What happens when your cancer becomes resistant to your course of treatment and progresses?
Dr. David Gandara, professor emeritus and co-director of UC Davis Comprehensive Cancer Center’s Center for Experimental Therapeutics, discussed a number of options. The good news is that it turns out there’s a lot that can be done if your cancer becomes resistant to its current targeted therapy (TKI) or immunotherapy. He explained that the options include understanding why your lung cancer became resistant through a re-biopsy of tissue or a blood biopsy, choosing a second or third generation TKI to better treat the progression, and adding a MET inhibitor drug if the cancer shows a MET amplification. Participating in a clinical trial may also be an option. Watch here.
